1-4 of 4
Ling Jiang, PhD MD
Close
Sort by
Journal Articles

A New Multi-Factor Risk Score System Depending on Gene Mutation and Overexpression for Predicting the Outcome in AML1-ETO-Positive Acute Myeloid Leukemia

Guo-Pan Yu, MD, Changxin Yin, Fuqun Wu, Dan Xu, Zhongxin Zheng, Ling Jiang, PhD MD, Fang Chen, Xuejie Jiang, MD, Qifa Liu, Fanyi Meng
Journal: Blood
Blood (2017) 130 (Supplement 1): 5088.
https://doi.org/10.1182/blood.V130.Suppl_1.5088.5088
Published: 2017
Journal Articles

Influence of FLT3-ITD Mutation and Length on the Prognosis in Acute Myeloid Leukemia

Xuejie Jiang, MD, Fang Chen, Changxin Yin, Ling Jiang, PhD MD, Guo-Pan Yu, MD, Dan Xu, Jing Sun, MD, Xiaoli Liu, MD PhD, Qifa Liu
Journal: Blood
Blood (2017) 130 (Supplement 1): 5089.
https://doi.org/10.1182/blood.V130.Suppl_1.5089.5089
Published: 2017
Journal Articles

MiR-144 Targets APP to Regulate AML1/ETO+ Leukemia Cell Migration Via p-ERK/c-Myc/MMP-2 Pathway

Fanyi Meng, Ling Jiang, PhD MD, Wei Meng, PhD, Guo-Pan Yu, MD, Yin Changxin, Zhixiang Wang, PhD, Xuejie Jiang, MD, Qifa Liu
Journal: Blood
Blood (2017) 130 (Supplement 1): 5093.
https://doi.org/10.1182/blood.V130.Suppl_1.5093.5093
Published: 2017
Journal Articles

Berberine Acts As a Putative Epigenetic Modulator By Affecting Histone Code in Acute Myelocytic Leukemia Cells

Zhixiang Wang, PhD, Qifa Liu, Xuejie Jiang, MD, Yu Zhang, PhD, Ling Jiang, PhD MD, Fanyi Meng
Journal: Blood
Blood (2017) 130 (Supplement 1): 4989.
https://doi.org/10.1182/blood.V130.Suppl_1.4989.4989
Published: 2017